Metastatic Breast Cancer

Shirley Mertz, MA, JD, Lisa Laudico, and Sheila McGlown share their stories of being diagnosed with metastatic breast cancer.

A caregiver discusses her wishes for a woman who was recently diagnosed with metastatic breast cancer. “Most of all I wish that time will stand still for her, so that she can crawl into bed with her children and hold them as long as she wants to, feeling their bodies curl into hers as they sleep,” she writes.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Rose Gerber, a breast cancer survivor and advocate, about disparities in cancer care, in particular in breast cancer.

A woman shares her thoughts on the number of oral medications she's taken to treat her metastatic breast cancer.

A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.

Olympic volleyball player, April Ross, explained in an interview with CURE® that seeing her mother’s dedication to her family, despite her diagnosis, helped put things into perspective and taught her what is truly important in life.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for April 2021.

A person with metastatic breast cancer writes about how she just wants to be “normal” again and for people to stop pitying her.

A patient with metastatic cancer writes about how the unknowns of her disease have shaped her life and health experiences, and how she has learned to live with that uncertainty.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.

Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.

A woman who is living with metastatic breast cancer pens a tribute to a late friend and fellow patient, Penny, who continues to send her signs that help her keep going.

A patient with metastatic cancer writes what it has been like to face the dilemma of receiving an effective cancer therapy that may put her heart at risk.

An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.

Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.

Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.

The FDA announced that a special committee will review the indications of several cancer drugs that were granted accelerated approval as confirmatory trials showed they failed to demonstrate efficacy.

As her seven-year cancerversary approaches, one patient with metastatic breast cancer shares why she is grateful to be a 'mutant'.

Vaccine eligibility forces this metastatic breast cancer patient to confront the value society places on her life.